Literature DB >> 12574348

Naturally occurring human IgM antibody that binds B7-DC and potentiates T cell stimulation by dendritic cells.

Suresh Radhakrishnan1, Loc T Nguyen, Bogoljub Ciric, Daren R Ure, Bin Zhou, Koji Tamada, Haidong Dong, Su-Yi Tseng, Tahiro Shin, Drew M Pardoll, Lieping Chen, Robert A Kyle, Moses Rodriguez, Larry R Pease.   

Abstract

A human IgM Ab, serum-derived human IgM 12 (sHIgM12), is identified that binds mouse and human dendritic cells (DC), inducing dramatic immunopotentiation following treatment of the mouse DC in vitro. Competition, transfection, and knockout studies identified the ligand on mouse DC as the costimulatory molecule family member B7-DC. Potent T cell responses are stimulated by Ag-pulsed DC treated with the sHIgM12 Ab in vitro and upon adoptive transfer of Ab-treated Ag-pulsed DC into animals. The multivalent structure of pentameric IgM provides the potential for cross-linking cell surface targets, endowing the soluble Abs with biological potential not normally associated with immune function. The ability of the sHIgM12 Ab to potentiate the immune response is dependent on the multimeric structure of IgM, as bivalent monomers do not retain this property. Furthermore, pretreatment of DC with IgM monomers blocks subsequent potentiation by intact IgM pentamers, an indication that cross-linking of B7-DC on the cell surface is critical for potentiation of Ag presentation. These findings imply that, in addition to known costimulatory roles, B7-DC can function as a receptor for signals delivered by cells expressing B7-DC ligands.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12574348     DOI: 10.4049/jimmunol.170.4.1830

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  L2pB1: a new player in autoimmunity.

Authors:  Xuemei Zhong; Thomas L Rothstein
Journal:  Mol Immunol       Date:  2010-12-31       Impact factor: 4.407

Review 2.  Role of PD-L1 and PD-L2 in allergic diseases and asthma.

Authors:  A K Singh; P Stock; O Akbari
Journal:  Allergy       Date:  2010-08-17       Impact factor: 13.146

Review 3.  The balance of immune responses: costimulation verse coinhibition.

Authors:  Sumit K Subudhi; Maria-Luisa Alegre; Yang-Xin Fu
Journal:  J Mol Med (Berl)       Date:  2005-01-04       Impact factor: 4.599

4.  B7-DC cross-linking restores antigen uptake and augments antigen-presenting cell function by matured dendritic cells.

Authors:  Suresh Radhakrishnan; Esteban Celis; Larry R Pease
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-01       Impact factor: 11.205

5.  Immunomodulation using the recombinant monoclonal human B7-DC cross-linking antibody rHIgM12.

Authors:  V P Van Keulen; B Ciric; S Radhakrishnan; K L Heckman; Y Mitsunaga; K Iijima; H Kita; M Rodriguez; L R Pease
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

6.  Co-inhibitory molecules: Controlling the effectors or controlling the controllers?

Authors:  Govindarajan Thangavelu; Christa Smolarchuk; Colin C Anderson
Journal:  Self Nonself       Date:  2010-02-16

7.  T-bet expression by dendritic cells is required for the repolarization of allergic airway inflammation.

Authors:  Karin L Heckman; Suresh Radhakrishnan; Tobias Peikert; Koji Iijima; Hugh C McGregor; Michael P Bell; Hirohito Kita; Larry R Pease
Journal:  Eur J Immunol       Date:  2008-09       Impact factor: 5.532

8.  Alternaria inhibits double-stranded RNA-induced cytokine production through Toll-like receptor 3.

Authors:  Kota Wada; Takao Kobayashi; Yoshinori Matsuwaki; Hiroshi Moriyama; Hirohito Kita
Journal:  Int Arch Allergy Immunol       Date:  2013-05-29       Impact factor: 2.749

Review 9.  How B cells shape the immune response against Mycobacterium tuberculosis.

Authors:  Paul J Maglione; John Chan
Journal:  Eur J Immunol       Date:  2009-03       Impact factor: 5.532

10.  Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.

Authors:  H Kaku; T L Rothstein
Journal:  Genes Immun       Date:  2009-08-27       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.